Annie Lintzenich Andrews1, Haley L Nitchie2, Jillian B Harvey2. 1. Department of Pediatrics, College of Medicine and andrewsan@musc.edu. 2. Department of Healthcare Leadership and Management, College of Health Professions, Medical University of South Carolina, Charleston, South Carolina.
Abstract
OBJECTIVES: Mobile technology-based asthma medication adherence interventions can be targeted to children during periods of high risk, including the transition from hospital to home or when refill behavior suggests declining adherence. Our objective was to develop insight into parent use of mobile technology and their preferences for a mobile technology-based asthma intervention. METHODS: By using qualitative methods, 20 interviews of parents of children with asthma were conducted. The open-ended, semistructured interview guides included questions about current mobile technology use, barriers to controller medication adherence, and preferences for methods and content of a mobile technology-based asthma intervention. Using grounded theory methodology, investigators coded the transcripts and identified emerging themes. RESULTS: Twenty parents completed interviews. Half of the children were 7 to 12 years old. Eighty percent had public insurance. Sixty-five percent had a previous hospitalization. Three major themes were identified: chronic disease management assistance, distinct preferences for risk communication, and electronic reachability. Chronic disease management assistance included parents recognizing that busy lifestyles contribute to adherence challenges and welcoming a program to assist them. Distinct preferences for risk communication included a preference for 2-way communication via text message or phone call at least monthly. Under the theme of electronic reachability, all enrolled parents had smartphones and used them daily. CONCLUSIONS: Parents of children with asthma are open to communicating with asthma providers through mobile technology. This information can be used to inform the development of mobile technology-based interventions to improve care for children with asthma during periods of high risk, including the transition from hospital to home.
OBJECTIVES: Mobile technology-based asthma medication adherence interventions can be targeted to children during periods of high risk, including the transition from hospital to home or when refill behavior suggests declining adherence. Our objective was to develop insight into parent use of mobile technology and their preferences for a mobile technology-based asthma intervention. METHODS: By using qualitative methods, 20 interviews of parents of children with asthma were conducted. The open-ended, semistructured interview guides included questions about current mobile technology use, barriers to controller medication adherence, and preferences for methods and content of a mobile technology-based asthma intervention. Using grounded theory methodology, investigators coded the transcripts and identified emerging themes. RESULTS: Twenty parents completed interviews. Half of the children were 7 to 12 years old. Eighty percent had public insurance. Sixty-five percent had a previous hospitalization. Three major themes were identified: chronic disease management assistance, distinct preferences for risk communication, and electronic reachability. Chronic disease management assistance included parents recognizing that busy lifestyles contribute to adherence challenges and welcoming a program to assist them. Distinct preferences for risk communication included a preference for 2-way communication via text message or phone call at least monthly. Under the theme of electronic reachability, all enrolled parents had smartphones and used them daily. CONCLUSIONS: Parents of children with asthma are open to communicating with asthma providers through mobile technology. This information can be used to inform the development of mobile technology-based interventions to improve care for children with asthma during periods of high risk, including the transition from hospital to home.
Authors: Juliet M Foster; Tim Usherwood; Lorraine Smith; Susan M Sawyer; Wei Xuan; Cynthia S Rand; Helen K Reddel Journal: J Allergy Clin Immunol Date: 2014-07-22 Impact factor: 10.793
Authors: William M Vollmer; Adrianne Feldstein; David H Smith; Joan P Dubanoski; Amy Waterbury; Jennifer L Schneider; Shelley A Clark; Cynthia Rand Journal: Am J Manag Care Date: 2011-12 Impact factor: 2.229
Authors: Chén C Kenyon; Siobhan M Gruschow; William O Quarshie; Heather Griffis; Michelle C Leach; Joseph J Zorc; Tyra C Bryant-Stephens; Victoria A Miller; Chris Feudtner Journal: J Asthma Date: 2018-02-13 Impact factor: 2.515
Authors: Amy H Y Chan; Alistair W Stewart; Jeff Harrison; Carlos A Camargo; Peter N Black; Edwin A Mitchell Journal: Lancet Respir Med Date: 2015-01-21 Impact factor: 30.700
Authors: Michiko Otsuki; Michelle N Eakin; Cynthia S Rand; Arlene M Butz; Van Doren Hsu; Ilene H Zuckerman; Jean Ogborn; Andrew Bilderback; Kristin A Riekert Journal: Pediatrics Date: 2009-12 Impact factor: 7.124
Authors: Kirk D Wyatt; Brian N Willaert; Christine M Lohse; Peter J Pallagi; James A Yiannias; Thomas R Hellmich Journal: Appl Clin Inform Date: 2020-02-12 Impact factor: 2.342
Authors: Ruchi S Gupta; Jamie L Fierstein; Kathy L Boon; Madeleine K Kanaley; Alexandria Bozen; Kristin Kan; Deneen Vojta; Christopher M Warren Journal: Pediatrics Date: 2021-01 Impact factor: 9.703
Authors: Cynthia F Corbett; Elizabeth M Combs; Peyton S Chandarana; Isabel Stringfellow; Karen Worthy; Thien Nguyen; Pamela J Wright; Jason M O'Kane Journal: JMIR Form Res Date: 2021-07-13